TY  - JOUR
AU  - Salto-Alejandre, Sonsoles
AU  - Palacios-Baena, Zaira R
AU  - Arribas, José Ramón
AU  - Berenguer, Juan
AU  - Carratalà, Jordi
AU  - Jarrín, Inmaculada
AU  - Ryan, Pablo
AU  - Miguel-Montero, Marta de
AU  - Rodríguez-Baño, Jesús
AU  - Pachón, Jerónimo
AU  - COVID-19@Spain Study Group
PY  - 2021
DO  - 10.1016/j.biopha.2021.112572
UR  - http://hdl.handle.net/10668/22040
T2  - Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie
AB  - Interferon-β is an attractive drug for repurposing and use in the treatment of COVID-19, based on its in vitro antiviral activity and the encouraging results from clinical trials. The aim of this study was to analyze the impact of early interferon-β...
LA  - en
KW  - COVID-19
KW  - Interferon-β
KW  - Mortality
KW  - SARS-CoV-2
KW  - Treatment
KW  - Aged
KW  - Aged, 80 and over
KW  - Antiviral Agents
KW  - COVID-19
KW  - Cohort Studies
KW  - Female
KW  - Hospitalization
KW  - Humans
KW  - Injections, Subcutaneous
KW  - Interferon-beta
KW  - Male
KW  - Prognosis
KW  - Retrospective Studies
KW  - SARS-CoV-2
KW  - Spain
KW  - Time-to-Treatment
KW  - Treatment Outcome
KW  - COVID-19 Drug Treatment
TI  - Impact of early interferon-β treatment on the prognosis of patients with COVID-19 in the first wave: A post hoc analysis from a multicenter cohort.
TY  - research article
VL  - 146
ER  -